50
Participants
Start Date
May 19, 2025
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
No Intervention
No investigational drug will be administered to participants in this study.
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
Boston Children's Hospital, Boston
Lead Sponsor
Astellas Gene Therapies
INDUSTRY